| human | Q5 |
| P4992 | DBA ID | beretz-alain |
| P646 | Freebase ID | /m/0h6fmp9 |
| P227 | GND ID | 1043055851 |
| P269 | IdRef ID | 067390145 |
| P213 | ISNI | 0000000355977524 |
| P6634 | LinkedIn personal profile ID | alainberetz |
| P8189 | National Library of Israel J9U ID | 987011295908505171 |
| P496 | ORCID iD | 0000-0002-1479-1697 |
| P1153 | Scopus author ID | 7003749803 |
| P214 | VIAF ID | 173259728 |
| P4124 | Who's Who in France biography ID | 64003 |
| P10832 | WorldCat Entities ID | E39PBJmDh3Wfj3gXQ9jjWB7T73 |
| P2002 | X username | alain_beretz |
| P166 | award received | Knight of the Legion of Honour | Q10855271 |
| Officer of the National Order of Merit | Q13422140 | ||
| Commander of the French Order of Academic Palms | Q14637188 | ||
| Order of the Rising Sun, Gold and Silver Star | Q55339172 | ||
| P3602 | candidacy in election | 2020 French municipal elections | Q60846649 |
| P27 | country of citizenship | France | Q142 |
| P69 | educated at | University of Strasbourg | Q157575 |
| P108 | employer | University of Strasbourg | Q157575 |
| Prime Minister of France | Q1587677 | ||
| Ministry of Higher Education and Research | Q2726949 | ||
| P734 | family name | Beretz | Q106065691 |
| Beretz | Q106065691 | ||
| Beretz | Q106065691 | ||
| P735 | given name | Alain | Q2829505 |
| Alain | Q2829505 | ||
| A. | Q19803442 | ||
| A. | Q19803442 | ||
| P1412 | languages spoken, written or signed | French | Q150 |
| German | Q188 | ||
| English | Q1860 | ||
| P1559 | name in native language | Alain Beretz | |
| P103 | native language | French | Q150 |
| P106 | occupation | university teacher | Q1622272 |
| pharmacologist | Q2114605 | ||
| P39 | position held | president | Q30461 |
| Plan S Ambassador | Q64577954 | ||
| ??? | Q56240280 | ||
| P21 | sex or gender | male | Q6581097 |
| Q69737590 | A simple in vitro model of mechanical injury of confluent cultured endothelial cells to study quantitatively the repair process |
| Q69490367 | An in vitro study of the interactions of plasma proteins with protein A-sepharose CL4B chromatography columns used to remove immunoglobulin G from human plasma |
| Q46691630 | Angiotensin II induces the vascular expression of VEGF and MMP-2 in vivo: preventive effect of red wine polyphenols. |
| Q67870176 | Antibodies to thrombomodulin induce receptor-mediated endocytosis in human saphenous vein endothelial cells |
| Q71766485 | Artifact of blood pressure recording using heparin-filled catheter: effects on blood pressure and coagulation parameters |
| Q68865666 | Behavior of confluent endothelial cells after irradiation. Modulation of wound repair by heparin and acidic fibroblast growth factor |
| Q70180982 | Cyclic nucleotide phosphodiesterase inhibitors prevent aggregation of human platelets by raising cyclic AMP and reducing cytoplasmic free calcium mobilization |
| Q35510137 | Cytokine production by human epithelial and endothelial cells following exposure to oral viridans streptococci involves lectin interactions between bacteria and cell surface receptors. |
| Q67904034 | Endothelial cell seeding: coating Dacron and expanded polytetrafluoroethylene vascular grafts with a biological glue allows adhesion and growth of human saphenous vein endothelial cells |
| Q67987270 | Epinephrine potentiates human platelet activation but is not an aggregating agent |
| Q72808577 | Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition |
| Q50237746 | FAK-mediated inhibition of vascular smooth muscle cell migration by the tetraspanin CD9. |
| Q40178050 | Flavonoid compounds are potent inhibitors of cyclic AMP phosphodiesterase |
| Q40215252 | Flavonoids are selective cyclic GMP phosphodiesterase inhibitors |
| Q72188975 | HIV-1 infection induces functional alterations in human liver endothelial cells in primary culture |
| Q41834727 | Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on the surface of human saphenous-vein endothelial cells in culture following stimulation by interleukin-1, tumour necrosis factor, thrombin or phorbol est |
| Q69433783 | Increased aggregation and secretion responses of human platelets when loaded with the calcium fluorescent probes quin2 and fura-2 |
| Q73791587 | Induction of NO production by polyosides from the wall of Streptococcus mutans OMZ175 in the rat aorta |
| Q40255530 | Inhibition of 3',5'–AMP Phosphodiesterase by Biflavonoids and Xanthones |
| Q72680510 | Inhibition of aggregation and secretion of human platelets by quercetin and other flavonoids: structure-activity relationships |
| Q70121544 | Inhibition of human platelet cyclic AMP phosphodiesterase and of platelet aggregation by a hemisynthetic flavonoid, amentoflavone hexaacetate |
| Q71239042 | Inhibitors of phosphodiesterase (pentoxifylline, trequinsin) inhibit apical and subcellular matrix expression of tissue factor in cultured human endothelial cells |
| Q39707646 | Intake of grape-derived polyphenols reduces C26 tumor growth by inhibiting angiogenesis and inducing apoptosis. |
| Q69792982 | Mitogenic activity on human arterial smooth muscle cells is increased in the plasma of patients undergoing hemodialysis with cuprophane membranes |
| Q71762377 | Naftazone accelerates human saphenous vein endothelial cell proliferation in vitro |
| Q77734025 | Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta |
| Q35025883 | Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta |
| Q54455020 | Non-immune interaction of erythrophilic IgG fractions with human red blood cells. |
| Q36709352 | Old and new natural products as the source of modern antithrombotic drugs. |
| Q67543151 | Opposing effects of heparin with TGF-beta or aFGF during repair of a mechanical wound of human endothelium. Influence of cAMP on cell migration |
| Q93652512 | Polyindolinic alkaloids from Psychotria forsteriana. Potent inhibitors of the aggregation of human platelets |
| Q45342187 | Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation. |
| Q44391225 | Red wine polyphenolic compounds inhibit vascular endothelial growth factor expression in vascular smooth muscle cells by preventing the activation of the p38 mitogen-activated protein kinase pathway. |
| Q42920423 | Role of cyclic AMP in promoting the thromboresistance of human endothelial cells by enhancing thrombomodulin and decreasing tissue factor activities |
| Q67253552 | Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin |
| Q69056695 | Sulfated polysaccharides modulate effects of acidic and basic fibroblast growth factors on repair of injured confluent human vascular endothelium |
| Q77544879 | Tetraspanin CD9 is associated with very late-acting integrins in human vascular smooth muscle cells and modulates collagen matrix reorganization |
| Q39529639 | The effect of flavonoids on blood-vessel wall interactions. |
| Q39502380 | The effects of flavonoids on cyclic nucleotide phosphodiesterases. |
| Q72163933 | Thrombin does not alter vascular hyporeactivity in models of endotoxin-induced septic shock in rats |
| Q42482650 | Thrombin regulates tissue factor and thrombomodulin mRNA levels and activities in human saphenous vein endothelial cells by distinct mechanisms. |
| Q70152230 | Tissue and substrate specificity of inhibition by alkoxy-aryl-lactams of platelet and arterial smooth muscle cyclic nucleotide phosphodiesterases relationship to pharmacological activity |
| Q72950290 | Tuftsin analogs for probing its specific receptor site on phagocytic cells |
| Q70200129 | Tuftsin receptors |
| Q42450745 | Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells |
| Q68649608 | [Flavonoids: antithrombotic agents or nutrients?] |
| Q68921397 | [Methods of studying platelet function. Biological markers of the activation of human platelets in vivo and in vitro] |
| Q70287808 | [Platelet aggregation: a tool for clinical investigation and pharmacological study. Methodology] |
| Q71448325 | [Thrombogenic properties of the vessel and their inhibition] |
| Q56242219 | Direction Générale de la Recherche et de l'Innovation | director / manager | P1037 |
| Q3551497 | Louis Pasteur University | chairperson | P488 |
| Category:Alain Beretz | wikimedia | |
| Alain Beretz | wikipedia |
Search more.